In an industry where products are appearing on shelves at a record pace, Genemarkers’ testing offers the opportunity to differentiate based on scientific evidence. Our off-the-self qPCR-based gene expression panels and RNA sequencing platform screen CBD, CBD-like compounds, and CBD-containing formulations in personal care products. Our partners use our services to validate efficacy, improve product formulations, investigate use levels, and identify biological mechanisms of action. Testing is performed with in-vitro or ex-vivo tissue samples and can typically be completed from start to finish in as little as 4-6 weeks. At the end of the study, Genemarkers will provide our findings via a comprehensive, easy-to-understand report and provides all the raw data to the sponsor for internal use.
Email Alisha Morrison at [email protected]
for more information.